AZN - AstraZeneca PLC

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 227.96B
Enterprise value 253.00B
Trailing P/E 48.86
Forward P/E 19.96
PEG ratio (5-yr expected) 2.23
Price/sales (ttm)5.25
Price/book (mrq)6.39
Enterprise value/revenue 5.77
Enterprise value/EBITDA 22.97

Trading information

Stock price history

Beta (5Y monthly) 0.18
52-week change 39.09%
S&P500 52-week change 31.77%
52-week high 376.56
52-week low 352.65
50-day moving average 372.56
200-day moving average 366.04

Share statistics

Avg vol (3-month) 34.04M
Avg vol (10-day) 33.73M
Shares outstanding 53.1B
Implied shares outstanding 6N/A
Float 818.6B
% held by insiders 10.01%
% held by institutions 118.10%
Shares short (14 May 2023) 44.67M
Short ratio (14 May 2023) 41.24
Short % of float (14 May 2023) 4N/A
Short % of shares outstanding (14 May 2023) 40.15%
Shares short (prior month 13 Apr 2023) 44.02M

Dividends & splits

Forward annual dividend rate 41.45
Forward annual dividend yield 42.02%
Trailing annual dividend rate 32.90
Trailing annual dividend yield 34.04%
5-year average dividend yield 42.80
Payout ratio 496.03%
Dividend date 326 Mar 2023
Ex-dividend date 422 Feb 2023
Last split factor 22:1
Last split date 326 Jul 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023

Profitability

Profit margin 10.73%
Operating margin (ttm)23.10%

Management effectiveness

Return on assets (ttm)6.43%
Return on equity (ttm)13.05%

Income statement

Revenue (ttm)43.84B
Revenue per share (ttm)2.35
Quarterly revenue growth (yoy)-4.50%
Gross profit (ttm)35.73B
EBITDA 14.89B
Net income avi to common (ttm)4.7B
Diluted EPS (ttm)1.51
Quarterly earnings growth (yoy)367.10%

Balance sheet

Total cash (mrq)6.46B
Total cash per share (mrq)0.35
Total debt (mrq)32.47B
Total debt/equity (mrq)90.68
Current ratio (mrq)0.90
Book value per share (mrq)1.92

Cash flow statement

Operating cash flow (ttm)9.71B
Levered free cash flow (ttm)9.69B